Literature DB >> 28325868

Inositol phosphates and phosphoinositides activate insulin-degrading enzyme, while phosphoinositides also mediate binding to endosomes.

Eun Suk Song1, HyeIn Jang1, Hou-Fu Guo1, Maria A Juliano2, Luiz Juliano2, Andrew J Morris3, Emilia Galperin1, David W Rodgers4,5, Louis B Hersh4,5.   

Abstract

Insulin-degrading enzyme (IDE) hydrolyzes bioactive peptides, including insulin, amylin, and the amyloid β peptides. Polyanions activate IDE toward some substrates, yet an endogenous polyanion activator has not yet been identified. Here we report that inositol phosphates (InsPs) and phosphatdidylinositol phosphates (PtdInsPs) serve as activators of IDE. InsPs and PtdInsPs interact with the polyanion-binding site located on an inner chamber wall of the enzyme. InsPs activate IDE by up to ∼95-fold, affecting primarily Vmax The extent of activation and binding affinity correlate with the number of phosphate groups on the inositol ring, with phosphate positional effects observed. IDE binds PtdInsPs from solution, immobilized on membranes, or presented in liposomes. Interaction with PtdInsPs, likely PtdIns(3)P, plays a role in localizing IDE to endosomes, where the enzyme reportedly encounters physiological substrates. Thus, InsPs and PtdInsPs can serve as endogenous modulators of IDE activity, as well as regulators of its intracellular spatial distribution.

Entities:  

Keywords:  activation; inositols; insulin-degrading enzyme; phosphatidylinositols; subcellular localization

Mesh:

Substances:

Year:  2017        PMID: 28325868      PMCID: PMC5389272          DOI: 10.1073/pnas.1613447114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  88 in total

1.  Fluorescence probes for critical micelle concentration determination.

Authors:  E D Goddard; N J Turro; P L Kuo; K P Ananthapadmanabhan
Journal:  Langmuir       Date:  1985-05       Impact factor: 3.882

2.  Functional relevance of a novel SlyX motif in non-conventional secretion of insulin-degrading enzyme.

Authors:  Konstantin Glebov; Sebastian Schütze; Jochen Walter
Journal:  J Biol Chem       Date:  2011-05-16       Impact factor: 5.157

3.  Degradation of intraendosomal insulin by insulin-degrading enzyme without acidification.

Authors:  F G Hamel; M J Mahoney; W C Duckworth
Journal:  Diabetes       Date:  1991-04       Impact factor: 9.461

4.  Anion activation site of insulin-degrading enzyme.

Authors:  Nicholas Noinaj; Eun Suk Song; Sonia Bhasin; Benjamin J Alper; Walter K Schmidt; Louis B Hersh; David W Rodgers
Journal:  J Biol Chem       Date:  2011-11-02       Impact factor: 5.157

Review 5.  Clearance systems in the brain-implications for Alzheimer disease.

Authors:  Jenna M Tarasoff-Conway; Roxana O Carare; Ricardo S Osorio; Lidia Glodzik; Tracy Butler; Els Fieremans; Leon Axel; Henry Rusinek; Charles Nicholson; Berislav V Zlokovic; Blas Frangione; Kaj Blennow; Joël Ménard; Henrik Zetterberg; Thomas Wisniewski; Mony J de Leon
Journal:  Nat Rev Neurol       Date:  2015-07-21       Impact factor: 42.937

6.  Degradation of insulin by isolated mouse pancreatic acini. Evidence for cell surface protease activity.

Authors:  I D Goldfine; J A Williams; A C Bailey; K Y Wong; Y Iwamoto; K Yokono; S Baba; R A Roth
Journal:  Diabetes       Date:  1984-01       Impact factor: 9.461

7.  Isolation of insulin degradation products from endosomes derived from intact rat liver.

Authors:  F G Hamel; B I Posner; J J Bergeron; B H Frank; W C Duckworth
Journal:  J Biol Chem       Date:  1988-05-15       Impact factor: 5.157

8.  Complex changes in cellular inositol phosphate complement accompany transit through the cell cycle.

Authors:  Christopher J Barker; Joanne Wright; Philip J Hughes; Christopher J Kirk; Robert H Michell
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

Review 9.  Lipid sorting and multivesicular endosome biogenesis.

Authors:  Christin Bissig; Jean Gruenberg
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-10-01       Impact factor: 10.005

10.  Insulin-degrading enzyme is exported via an unconventional protein secretion pathway.

Authors:  Ji Zhao; Lilin Li; Malcolm A Leissring
Journal:  Mol Neurodegener       Date:  2009-01-14       Impact factor: 14.195

View more
  10 in total

Review 1.  Hepatic Insulin Clearance: Mechanism and Physiology.

Authors:  Sonia M Najjar; Germán Perdomo
Journal:  Physiology (Bethesda)       Date:  2019-05-01

2.  The insulin-degrading enzyme is an allosteric modulator of the 20S proteasome and a potential competitor of the 19S.

Authors:  Diego Sbardella; Grazia R Tundo; Andrea Coletta; Julien Marcoux; Efthymia Ioanna Koufogeorgou; Chiara Ciaccio; Anna M Santoro; Danilo Milardi; Giuseppe Grasso; Paola Cozza; Marie-Pierre Bousquet-Dubouch; Stefano Marini; Massimo Coletta
Journal:  Cell Mol Life Sci       Date:  2018-03-28       Impact factor: 9.261

Review 3.  Targeting Insulin-Degrading Enzyme in Insulin Clearance.

Authors:  Malcolm A Leissring; Carlos M González-Casimiro; Beatriz Merino; Caitlin N Suire; Germán Perdomo
Journal:  Int J Mol Sci       Date:  2021-02-24       Impact factor: 5.923

Review 4.  Insulin-Degrading Enzyme, an Under-Estimated Potential Target to Treat Cancer?

Authors:  Laetitia Lesire; Florence Leroux; Rebecca Deprez-Poulain; Benoit Deprez
Journal:  Cells       Date:  2022-04-05       Impact factor: 6.600

5.  Insulin-degrading enzyme is not secreted from cultured cells.

Authors:  Eun Suk Song; David W Rodgers; Louis B Hersh
Journal:  Sci Rep       Date:  2018-02-05       Impact factor: 4.379

Review 6.  The cell biology of systemic insulin function.

Authors:  Victoria L Tokarz; Patrick E MacDonald; Amira Klip
Journal:  J Cell Biol       Date:  2018-04-05       Impact factor: 10.539

Review 7.  Modulation of Insulin Sensitivity by Insulin-Degrading Enzyme.

Authors:  Carlos M González-Casimiro; Beatriz Merino; Elena Casanueva-Álvarez; Tamara Postigo-Casado; Patricia Cámara-Torres; Cristina M Fernández-Díaz; Malcolm A Leissring; Irene Cózar-Castellano; Germán Perdomo
Journal:  Biomedicines       Date:  2021-01-17

8.  Insulin-Degrading Enzyme: Paradoxes and Possibilities.

Authors:  Malcolm A Leissring
Journal:  Cells       Date:  2021-09-16       Impact factor: 6.600

9.  Altered Surface Expression of Insulin-Degrading Enzyme on Monocytes and Lymphocytes from COVID-19 Patients Both at Diagnosis and after Hospital Discharge.

Authors:  Carlos M González-Casimiro; Elisa Arribas-Rodríguez; Aida Fiz-López; Javier Casas; Sara Gutiérrez; Pablo Tellería; Cristina Novoa; Silvia Rojo-Rello; Eduardo Tamayo; Antonio Orduña; Carlos Dueñas; David Bernardo; German Perdomo
Journal:  Int J Mol Sci       Date:  2022-09-21       Impact factor: 6.208

10.  Evolutionary Origin of Insulin-Degrading Enzyme and Its Subcellular Localization and Secretion Mechanism: A Study in Microglial Cells.

Authors:  Miriam Corraliza-Gómez; Concepción Lillo; Irene Cózar-Castellano; Eduardo Arranz; Diego Sanchez; Maria D Ganfornina
Journal:  Cells       Date:  2022-01-11       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.